AstraZeneca (Q731938)

https://www.lanacion.com.ar/politica/alberto-fernandez-xx-nid2419369

biotechnology

0 references

inception

1913

1 reference

https://www.astrazeneca.ch/en/about-us/our-history.html

3 October 2023

logo image

Astrazeneca text logo.svg
300 × 43; 7 KB

0 references

image

AstraZeneca HQ in Cambridge UK.jpg
4,032 × 3,024; 3.83 MB

1 reference

https://en.wikipedia.org/w/index.php?title=AstraZeneca&oldid=1058759419

English Wikipedia

Wikimedia import URL

official name

AstraZeneca PLC (English)

1999

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Zeneca Group PLC (English)

February 1993

end time

1999

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

chief executive officer

Pascal Soriot

2006

1 reference

https://www.astrazeneca.com/our-company/leadership.html

chairperson

Leif Johansson

26 April 2012

1 reference

https://beta.companieshouse.gov.uk/officers/UR_GVtQ1C0JXN1sNFXzVIMUQz4I/appointments

board member

Leif Johansson

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

1 reference

public limited company

1 reference

German Wikipedia

total assets

61,377,000,000 United States dollar

31 December 2019

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

60,651,000,000 United States dollar

31 December 2018

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

53,354,000,000 United States dollar

31 December 2017

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

62,526,000,000 United States dollar

31 December 2016

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

60,056,000,000 United States dollar

31 December 2015

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

total equity

14,596,000,000 United States dollar

31 December 2019

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

14,044,000,000 United States dollar

31 December 2018

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

16,642,000,000 United States dollar

31 December 2017

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

16,669,000,000 United States dollar

31 December 2016

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

18,509,000,000 United States dollar

31 December 2015

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

total revenue

24,384,000,000 United States dollar

2019

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

22,090,000,000 United States dollar

2018

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

22,465,000,000 United States dollar

2017

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

23,002,000,000 United States dollar

2016

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

24,708,000,000 United States dollar

2015

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

net profit

1,227,000,000 United States dollar

2019

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

2,050,000,000 United States dollar

2018

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

2,868,000,000 United States dollar

2017

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

6,406,000,000 United States dollar

2016

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

2,826,000,000 United States dollar

2015

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

operating income

2,924,000,000 United States dollar

2019

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

3,387,000,000 United States dollar

2018

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

3,677,000,000 United States dollar

2017

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

4,902,000,000 United States dollar

2016

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

4,116,000,000 United States dollar

2015

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

location of formation

Cambridge

1 reference

7.69 percent

4 December 2009

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

3.93 percent

3 April 2019

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Capital Group Companies

4.86 percent

17 July 2018

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Wellington Management Company

5.89 percent

3 October 2019

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

parent organization

no value

0 references

has subsidiary

AstraZeneca Canada

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

2 references

grid.418151.8

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

2 references

grid.459399.b

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

AstraZeneca Farmaceutica Spain

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

AstraZeneca Czech Republic

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Cambridge Antibody Technology

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

AstraZeneca (United States)

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Amylin Pharmaceuticals

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

50 percent

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Montrose Chemical Corporation of California

50 percent

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

6.66 percent

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Circassia Pharmaceuticals

18.9 percent

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

16.29 percent

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

7.65 percent

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

PhaseBio Pharmaceuticals (United States)

10.44 percent

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

Cambridge Biomedical Campus

headquarters location

Cambridge

coordinate location

52°10'29.3124"N, 0°7'58.1826"E

postal code

CB2 0AA

country

United Kingdom

0 references

0 references

stock exchange

New York Stock Exchange

ticker symbol

AZN

6 April 1999

1 reference

Astrazeneca PLC

20 February 2021

London Stock Exchange

ticker symbol

AZN

0 references

Nasdaq Stockholm AB

ticker symbol

AZN

0 references

employees

70,600

2019

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

64,600

2017

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

61,100

2016

1 reference

https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf

0 references

180,898 tonne of carbon dioxide equivalent

1 January 2023

31 December 2023

1 reference

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

19,940 tonne of carbon dioxide equivalent

1 January 2023

31 December 2023

1 reference

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

183,332 tonne of carbon dioxide equivalent

object has role

Scope 2 location-based

1 January 2023

31 December 2023

1 reference

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

6,736,878 tonne of carbon dioxide equivalent

1 January 2023

31 December 2023

1 reference

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

4,622,257 tonne of carbon dioxide equivalent

1 January 2023

31 December 2023

Purchased goods and services

1 reference

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

81,938 tonne of carbon dioxide equivalent

1 January 2023

31 December 2023

1 reference

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

52,634 tonne of carbon dioxide equivalent

1 January 2023

31 December 2023

Fuel- and energy-related activities

1 reference

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

241,422 tonne of carbon dioxide equivalent

1 January 2023

31 December 2023

Upstream transportation and distribution

1 reference

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

19,043 tonne of carbon dioxide equivalent

1 January 2023

31 December 2023

Waste generated in operations

1 reference

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

155,443 tonne of carbon dioxide equivalent

1 January 2023

31 December 2023

1 reference

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

50,827 tonne of carbon dioxide equivalent

1 January 2023

31 December 2023

1 reference

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

30,101 tonne of carbon dioxide equivalent

1 January 2023

31 December 2023

Upstream leased assets

1 reference

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

135,689 tonne of carbon dioxide equivalent

1 January 2023

31 December 2023

Downstream transportation and distribution

1 reference

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

1,330,844 tonne of carbon dioxide equivalent

1 January 2023

31 December 2023

1 reference

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

14,579 tonne of carbon dioxide equivalent

1 January 2023

31 December 2023

End-of-life treatment of sold products

1 reference

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

2,101 tonne of carbon dioxide equivalent

1 January 2023

31 December 2023

Downstream leased assets

1 reference

https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf

product or material produced or service provided

medication

0 references

official website

http://www.astrazeneca.com/

language of work or name

English

1 reference

http://www.fundinguniverse.com/company-histories/astrazeneca-plc-history/

English Wikipedia

described at URL

0 references

AstraZeneca

https://www.medvik.cz/link/nlk20030129777

1 reference

Medvik

9 October 2020

social media followers

228,185

10 January 2021

0 references

142,600

10 May 2018

0 references

298,516

21 February 2022

0 references

304,575

7 February 2023

0 references

different from

AZD1222

1 reference

https://pl.wikipedia.org/w/index.php?title=AstraZeneca&oldid=63365095

Polish Wikipedia

Wikimedia import URL

Commons category

AstraZeneca

0 references

topic's main category

Category:AstraZeneca

0 references

Identifiers

Legal Entity Identifier

PY6ZZQWO2IZFZC3IOL08

0 references

ISIN

GB0009895292

1 reference

Virtual International Authority File

1 reference

5 August 2015

1 reference

10.6084/M9.FIGSHARE.4539889

1 reference

Bibliothèque nationale de France ID

1 reference

26 August 2015

1 reference

https://de.wikipedia.org/w/index.php?title=AstraZeneca&oldid=205973128

German Wikipedia

Wikimedia import URL

FAST ID

1995186

0 references

National Library of Israel J9U ID

987011066432105171

1 reference

National Library of Israel Names and Subjects Authority File

Library of Congress authority ID

no2010135192

subject named as

AstraZeneca (Firm)

1 reference

Virtual International Authority File

6 March 2019

AstraZeneca

1 reference

VIAF ID

154100491

Virtual International Authority File

Portuguese National Library author ID

17 December 2018

0 references

1 reference

26 August 2015

WorldCat Identities ID (superseded)

1 reference

0 references

Brockhaus Enzyklopädie online ID

0 references

1 reference

Astrazeneca PLC

20 February 2021

1 reference

https://www.channelnewsasia.com/news/topic/astrazeneca

ASTRAZENECA latest news & coverage (English)

Companies House company ID

20 July 2021

02723534

0 references

Comparably company ID

astrazeneca-plc

1 reference

https://www.comparably.com/companies/astrazeneca-plc

Astrazeneca PLC Company Culture | Comparably (English)

Crunchbase organization ID

4 March 2022

2 references

http://km.aifb.kit.edu/services/crunchbase/

D-U-N-S number

230790719

0 references

Dagens Nyheter topic ID

0 references

AstraZeneca

0 references

Den Store Danske ID

AstraZeneca

0 references

EU Transparency Register ID

42561875992-94

reason for deprecated rank

withdrawn identifier value

0 references

249402638316-62

object named as

AstraZeneca PLC

1 reference

June 2023

1 reference

Google Knowledge Graph

30 September 2020

1 reference

28 October 2013

1 reference

https://www.glassdoor.sg/Overview/Working-at-AstraZeneca-EI_IE9214.11,22.htm?countryRedirect=true

https://golden.com/wiki/AstraZeneca-PY54V

Working at AstraZeneca | Glassdoor (English)

7 November 2021

1 reference

10 September 2022

Google Scholar organization ID

992515209104559621

0 references

Great Russian Encyclopedia portal ID

astrazeneca-a9c2fa

0 references

GRID ID

grid.417815.e

2 references

GRID Release 2015-12-14

GRID Release 2016-12-06

Instagram username

astrazeneca

1 reference

Google Knowledge Graph

LinkedIn company or organization ID

30 September 2020

Freebase ID

/m/028zbs

astrazeneca

1 reference

https://www.linkedin.com/company/astrazeneca/

AstraZeneca: Overview | LinkedIn (English)

Open Funder Registry funder ID

4 August 2021

Microsoft Academic ID

105036370

0 references

NE.se ID

astrazeneca-plc

0 references

1 reference

grid.417815.e

0 references

0 references

1 reference

AstraZeneca UK Ltd

1 reference

Aligned ISNI and Ringgold identifiers for institutions

4625

subject named as

AstraZeneca plc

1 reference

Aligned ISNI and Ringgold identifiers for institutions

0 references

AstraZeneca

0 references

UK Parliament thesaurus ID

2690

subject named as

AstraZeneca

0 references

University of Barcelona authority ID

1 reference

0 references

number of subscribers

142,600

10 May 2018

verified account or profile